Elliott M. Antman
Brigham and Women's Hospital
765 Papers
17.4K Citations
Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & Medicine. The author has an hindex of 161, co-authored 716 publications. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.
Chat about Author
Papers
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma
Hyung Cheol Park,Thaddeus Tarpey,Mengling Liu,Keith Goldfeld,Yinxiang Wu,Danni Wu,Yi Hwei Li,Jinchun Zhang,Dipyaman Ganguly,Yogiraj Ray,S. R. Paul,Prasun Bhattacharya,Artur Belov,Yingzi Huang,C. Villa,Richard A. Forshee,Nicole C. Verdun,Hyun Ah Yoon,Anup Agarwal,Ventura A Simonovich,Paula Scibona,Leandro Burgos Pratx,Waldo H. Belloso,Cristina Avendaño-Solá,Katharine J. Bar,Rafael F. Duarte,Priscilla Y. Hsue,Anne F Luetkemeyer,Geert Meyfroidt,André Moraes Nicola,Aparna Mukherjee,Mila Brum Ortigoza,Liise Anne Pirofski,Bart J. A. Rijnders,Andrea B. Troxel,Elliott M. Antman,Eva Petkova +36 more
TL;DR: This prognostic study of 2287 patients hospitalized with COVID-19 identified a combination of baseline characteristics that predict a gradation of benefit from CCP compared with treatment without CCP.
Time Is Muscle: Translation Into Practice
TL;DR: Improvements in access to timely care for patients with STEMI will require a multifaceted approach involving patient education, improvements in the Emergency Medical Services and emergency department components of care, as well as coordinated advocacy efforts to work with payers and policy makers to implement a much-needed health care system redesign.
Magnesium in acute myocardial infarction: overview of available evidence.
TL;DR: Although the ISIS-4 study enrolled more than 58,000 patients, no reduction in mortality was seen, probably as a result of a low control group mortality and relatively late administration of the magnesium.
Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with st-segment elevation myocardial infarction
C. Michael Gibson,Sabina A. Murphy,Ajay J. Kirtane,Ajay J. Kirtane,Robert P. Giugliano,Christopher P. Cannon,Elliott M. Antman,Eugene Braunwald +7 more
TL;DR: A prolonged symptom to treatment time among STEMI patients is associated with impaired myocardial perfusion independent of epicardial flow both immediately after fibrinolytic administration and after rescue/adjunctive PCI, and these data provide a pathophysiologic link between prolonged symptoms due to vessel occlusion, impaired my cardiac perfusion, and poor clinical outcomes.